Hope S. Rugo has joined City of Hope as the new director of the Women’s Cancers Program
City of Hope shared a post on LinkedIn:
“We are excited to share Hope S. Rugo, M.D., has joined City of Hope as the new director of the Women’s Cancers Program, division chief of Breast Medical Oncology and professor in the Department of Medical Oncology and Therapeutics Research.
In her role, Dr. Rugo will lead and enhance City of Hope’s women’s cancers research and clinical care — expanding clinical trials, advancing translational research and standardizing care to drive superior patient outcomes and experiences.
A globally recognized leader in breast cancer research, Dr. Rugo has contributed to pivotal studies that led to the approval of treatments including PARP inhibitors, CDK4/6 inhibitors, PI3K inhibitors, checkpoint inhibitors and antibody-drug conjugates.
Beyond research, Dr. Rugo is a dedicated clinician and educator, committed to compassionate, leading-edge care for every patient.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023